WellQuest Issues Shareholder Report

BENTONVILLE, AR--(Marketwired - Aug 29, 2013) - WellQuest Medical & Wellness Corporation (the "Company" or "WellQuest") (PINKSHEETS: WEQL), delivering a unique model for healthcare that helps customers get well, stay well, and look well, has issued a Shareholder Report outlining the Company's recent achievements:
Key highlights from the Shareholder Report include:

  • The Company's flagship WellQuest health and wellness center in Bentonville, Arkansas posted record net revenues of $4.2 million in 2012 with net income for the center of $602,000; consolidated net income from operations was $93,000 in 2012

  • WellQuest of Tulsa, the Company's first replicated expansion site is slated to open this fall

  • 10,000 sq. ft. Tulsa facility to deliver family medicine, pediatrics, diagnostics, wellness, aesthetics, retail products and corporate wellness programs

  • Mechanism for financing expansion was not dilutive to Company's underlying common stock and puts appreciating assets on WellQuest's balance sheet

  • Having created the model for replication with minimized dilution to shareholders, WellQuest has hired two executives to manage growth; Mike Wernli as VP of Operations and Jeremy Cavness as Director of Sales and Marketing

To view the Shareholder Report in full, please visit: http://wellquestmedical.com/docs/ShareholdersReport.pdf

About WellQuest Medical & Wellness Corporation
WellQuest offers its innovative concept in healthcare delivery by integrating conventional and complementary physician medicine with wellness, and aesthetic services in one center, creating an effective environment for the pursuit and maintenance of a healthy life. WellQuest's unique model for healthcare helps customers get well, stay well, and look well. Currently operating in Bentonville, Arkansas, WellQuest seeks to open additional locations in the U.S.

Forward-LookingStatements
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to, the Company's ability to obtain the necessary financing to continue and expand operations, to market its products and services in new markets and to offer healthcare services at competitive pricing, anticipated revenue from client visits; general economic conditions and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. These statements include, without limitation, statements regarding our ability to prepare the Company for growth; the Company's planned expansions, and predictions and guidance relating to the Company's future financial performance. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise